Affordable Access

deepdyve-link deepdyve-link
Publisher Website

A decision-tree approach to cost comparison of newborn screening strategies for cystic fibrosis.

Authors
Type
Published Article
Journal
PEDIATRICS
1098-4275
Publisher
American Academy of Pediatrics
Publication Date
Volume
129
Issue
2
Identifiers
DOI: 10.1542/peds.2011-0096
PMID: 22291119
Source
Medline
License
Unknown

Abstract

The IRT/IRT screening algorithm reduces the costs to laboratories and insurance companies but has more system failures. IRT/DNA offers other advantages, including fewer delayed diagnoses and lower out-of-pocket costs to families.

Statistics

Seen <100 times